These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23235)

  • 21. [Experimental studies with timolol: a new ocular hypotensive agent (author's transl)].
    Vareilles P; Schmitt C; Lotti VJ; Le Douarec JC
    J Fr Ophtalmol; 1978 Dec; 1(12):717-21. PubMed ID: 155095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological effects of topical timolol in the rabbit eye.
    Bartels SP; Roth HO; Jumblatt MM; Neufeld AH
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1189-97. PubMed ID: 6106643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of timolol maleate on the disruption of the blood-aqueous barrier in the rabbit eye.
    Holmdahl G; Bengtsson E
    Invest Ophthalmol Vis Sci; 1981 Jun; 20(6):726-32. PubMed ID: 6113220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Timolol maleate (Blocadren) in the treatment of essential hypertension.
    O'Brien KP
    N Z Med J; 1975 Nov; 82(551):293-6. PubMed ID: 1695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1).
    Meekers J; Missotten A; Fagard R; Demuynck D; Harvengt C; Pas P; Billiet L; Amery A
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):294-306. PubMed ID: 238480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract]   [Full Text] [Related]  

  • 27. Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.
    Brazier DJ; Smith SE
    Br J Ophthalmol; 1988 Feb; 72(2):101-3. PubMed ID: 3349009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of ocular drugs. 1. Timolol maleate.
    Kaufman HE
    Ophthalmology; 1980 Feb; 87(2):164-8. PubMed ID: 6104319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):98-101. PubMed ID: 25846
    [No Abstract]   [Full Text] [Related]  

  • 30. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential inhibition of beta adrenergic receptors in human and rabbit ciliary process and heart.
    Nathanson JA
    J Pharmacol Exp Ther; 1985 Jan; 232(1):119-26. PubMed ID: 2856938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A further study on antihypertensive action of beta-adrenoceptor blocking agents in conscious, renal hypertensive dogs.
    Himori N; Ishimori T; Taira N
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):115-27. PubMed ID: 44454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacologic observations on timolol. I. Disposition and effect in relation to plasma level in normal individuals.
    Ishizaki T; Tawara K; Oyama Y; Nakaya H
    J Clin Pharmacol; 1978; 18(11-12):511-8. PubMed ID: 721948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of timolol on isoprenaline induced cyclic adenosine monophosphate production in human isolated lymphocytes [proceedings].
    Reed M; Davy CR; Greenacre JK; Davies RJ; Turner P
    Br J Clin Pharmacol; 1979 Apr; 7(4):433P. PubMed ID: 220997
    [No Abstract]   [Full Text] [Related]  

  • 35. Investigations on the antihypertensive activity of timolol and bendroflumethiazide and the combination in dogs and rats.
    Nielsen KC; Olsen UB; Ronne A; Arrigoni-Martelli E
    Acta Pharmacol Toxicol (Copenh); 1976; 39(5):500-12. PubMed ID: 990034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic and systemic side effects of ocular beta-adrenergic antagonists in anesthetized dogs.
    Svec AL; Strosberg AM
    Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):401-5. PubMed ID: 2869005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-blocking drug metipranolol: plasma levels and pharmacodynamic action in man.
    Mayer O; Cepelák V; Vitous J; Potmĕsil J
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):113-9. PubMed ID: 6103879
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta 1- and beta 2-adrenoceptor subtypes in canine intrathoracic efferent sympathetic nervous system regulating the heart.
    Watson-Wright W; Boudreau G; Cardinal R; Armour JA
    Am J Physiol; 1991 Nov; 261(5 Pt 2):R1269-75. PubMed ID: 1683175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The demonstration of atenolol as a beta-adrenoceptor blocking drug in man.
    Harry JD
    Postgrad Med J; 1977; 53 Suppl 3():65-9. PubMed ID: 928268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.